Chance Pharmaceuticals Secures $30 Million Series C Funding ...
Hangzhou, China, October 11, 2021 (GLOBE Newswire) — Chance Pharmaceuticals (“Chance”), a clinical-s...
Aerami Therapeutics Initiates Dosing in Phase 1 Trial of AER...
Thank you for walking along the way ——Chance Pharmaceutical'...
Chance Pharmaceutical won the honorary title of "Top Te...
Hangzhou Chance Pharmaceuticals Appoints Guobao Zhao as Seni...
Moon is full of Mid-Autumn Festival, full of love in Chance
Hangzhou Chance Pharmaceuticals Announces NMPA Acceptance of...
Dr. Lan Chen, Senior Vice President of Chance Pharmaceutical...
West Creek Valley Walk 【Chance Pharmaceutical May S...
Chance Pharmaceutical has been on the list of Hangzhou quasi...
The final battle of "Chance Cup" table tennis comp...
Caring for employees, caring for health
Chance Pharmaceutical was recognized as a small and medium-s...